Rite Aid (RAD -7.29%) has been one of Wall Street's top performers this year as the company's restructuring plan has returned it to profitability.
However, Rite Aid's plans to improve working capital and profitability by outsourcing generic drug purchasing to McKesson (MCK 0.37%) hit a snag last quarter that weighed on profit.
In the following slideshow, I've included 18 quotes from Rite Aid's management that provide insight into five subjects: the McKesson headwind, Obamacare's impact, expansion plans, health care clinics, and guidance for the remainder of this year.
